Endometriosis, a common condition affecting 5-10% of women of reproductive age, is the growth of endometrial-like tissue outside the uterus, leading to pain and infertility. Current treatments, such as surgery …
Endometriosis presents a common and significant health burden affecting approximately 1 in 10 reproductive age patients who are assigned female at birth. Recently guidelines have begun shifting away from laparoscopy …
Role of SMOC2 in adenomyosis: implications for ECM remodeling and EMT pathogenesis BMC Women's Health
Endometriosis is marked by the ectopic growth, spread, and invasion of endometrial tissue beyond the uterus, resulting in recurrent bleeding, pain, reproductive challenges, and the formation of nodules or masses. …
Endometriosis is caused by the migration of endometrial cells to locations outside the uterine lining. Despite the increasing prevalence of endometriosis, there has been limited research on genetic effects, and …
Emerging evidence suggests that aberrantly expressed microRNAs (miRNAs) participate in endometriosis pathogenesis. miR-1229-5p participates in the pathogenesis of several disease, but its precise role and mechanism in endometriosis is unclear.
Canadian Biotech Afynia Raises $5M to Commercialize Blood Test for Endometriosis Femtech Insider
UK’s SBRI Healthcare Awards £1.3M to 14 Women’s Health Innovations Femtech Insider
Matrix metalloproteinases (MMPs) cleave proteins of extracellular matrix thus facilitating cellular invasion and cancer progression. High MMP-2 activity is frequently reported in several diseases including endometriosis and cancer. Endometriosis, though …